Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individual Patient Data Meta-Analysis of Prospective Studies of Patients Treated With the GORE® VIABAHN® Endoprosthesis With Heparin Bioactive Surface (VSX) for Peripheral Arterial Disease (INSIGHT VSX)

NCT05459818 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT05459818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05459818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individual Patient Data Meta-Analysis of Prospective Studies of Patients Treated With the GORE® VIABAHN® Endoprosthesis With Heparin Bioactive Surface (VSX) for Peripheral Arterial Disease (INSIGHT VSX)
Lead sponsor
Rijnstate Hospital
Phase
Observational
Overall status
Completed
Start date
October 12, 2022
Completion date
October 1, 2025
Enrollment
977 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular diseases